If you need more lookups,
subscriptions start at $34 USD/month.
Mark Spengler Location
Bremen, Germany
Mark Spengler Work
Senior Director Business Development @ (September 2023 - Present)
GLP Test Facility Management @ (July 2016 - September 2023)
Chief Executive Officer @ (February 2014 - September 2023)
Director Global Business Development @ (February 2014 - September 2023)
Director Project Management @ (February 2010 - August 2019)
Product Manager @ (June 2008 - February 2010)
R and D-Scientist and CSO @ G.A.G Biotech GmbH (April 2000 - March 2003)
Mark Spengler Education
Technische Universität Dortmund
Dr. (Chemistry, Biological and Chemical Microstructuring)
2003-2007
University of Bremen
Diol. Biol. (Biology, Biotechnology and molecular Genetics)
1994-1999
Mark Spengler Skills
Assay Development
Biotechnology
Protein Chemistry
Drug Discovery
Drug Development
Biopharmaceuticals
Clinical Development
Immunology
Validation
Pharmaceutical Industry
GLP
Technology Transfer
R&D
Lifesciences
Life Sciences
Project Management
Product Development
Biomarkers
Bioanalysis
Biochemistry
IND
Key Account Management
International Sales
Oncology
CRO
Sales
Customer Service
Lead Generation
Vaccines
Antibodies
Business Development
Compliance
Clinical Trials
Molecular Biology
Leadership
Administration
FDA
EMEA
Pharmacokinetics
Pharmacodynamics
Good Laboratory Practice (GLP)
Good Laboratory Practice Glp
Strategic Planning
Program Management
Science
Good Laboratory Practice
Mark Spengler Summary
Mark Spengler, based in Bremen, Germany, is currently a Senior Director Business Development at BioAgilytix. Mark Spengler brings experience from previous roles at Chimera Biotec. Mark Spengler holds a 2003 - 2007 Dr. in Chemistry, Biological and Chemical Microstructuring @ Technische Universität Dortmund. With a robust skill set that includes Assay Development, Biotechnology, Protein Chemistry, Drug Discovery, Drug Development and more. Mark Spengler has 2 emails on RocketReach.
Looking for a different Mark Spengler?
Find contact details for 700 million professionals.